Medtronic and private equity firm Carlyle Group reportedly entered negotiations over two units the medtech giant put on the spinoff block. Nearly a year ago, Medtronic announced its intention to pursue a separation of its Patient Monitoring and Respiratory Interventions businesses. Both are part of the company’s Medical Surgical portfolio. Months later, reports surfaced citing […]
Mergers & Acquisitions
Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B
MedAlliance announced today that Cordis acquired it for a total consideration that could reach up to $1.135 billion. The companies initially announced the planned deal in October of last year. Cordis, which develops interventional cardiovascular and endovascular technologies, made a $35 million investment last year. Its upfront closing payment totals $200 million, with achievement milestones […]
Siemens Healthineers’ Varian acquires oncology solutions company Aspekt Solutions
Varian, a Siemens Healthineers company, announced today that it acquired oncology solutions provider Aspekt Solutions. Aspekt Solutions provides medical physics, dosimetry and strategy consultation services. The acquisition aims to expand Varian’s advanced oncology solutions (AOS) offerings. Palo Alto, California-based Varian wants to increase the ability to address the rising demand for customized services and standardized […]
Enovis to acquire LimaCorporate for more than $840M
Enovis (NYSE:ENOV) announced today that it entered into a definitive agreement to acquire orthopedic implant maker LimaCorporate. Wilmington, Delaware-based Enovis — one of the 10 largest orthopedic companies in the world — values the deal at approximately $846.4 million (€800 million). The deal includes a $740.6 million (€700 million) cash payment at closing. The remaining […]
Abbott completes Bigfoot Biomedical acquisition
Abbott announced today that it completed its previously announced acquisition of Bigfoot Biomedical. Pursuant to the terms of the merger agreement, upon completion, Bigfoot became a wholly-owned subsidiary of Abbott. The companies declined to disclose financial terms. Abbott announced on Sept. 5 that it entered into a definitive agreement to acquire the smart insulin management […]
Boston Scientific targets M&A, AI to reach ‘next level’
Mike Mahoney uses fantasy football to describe Boston Scientific : He says that, if creating a medtech team, “it would be the draft you want.” Speaking at the company’s 2023 Investor Day event, the CEO set the theme as “next level.” He explained his aim to make Boston Scientific a “compelling” and “fantastic place to […]
Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M
Boston Scientific announced today that it entered into a definitive agreement to acquire Relievant Medsystems. The transaction includes an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for chronic pain. The minimally invasive, FDA-cleared, […]
Inogen completes Physio-Assist acquisition
Inogen (Nasdaq: INGN) announced today that it completed its previously announced acquisition of Physio-Assist. Goleta, California-based Inogen announced its plan to acquire the French airway clearance technology developer in July. The deal includes a $32 million payment upfront and could reach up to $45 million in total. Physio-Assist develops and manufactures its Simeox technology. Simeox, […]
Bausch+Lomb launches $1.4B offering to finance XIIDRA eye drop buy
Bausch + Lomb (NYSE:BLCO) announced today that it launched an offering worth $1.4 billion in new senior secured notes. The company intends to offer the notes, due 2028, and to enter into an incremental term loan facility. Both moves aim to support the financing of the company’s pending acquisition of XIIDRA. Bausch + Lomb expects […]
Centinel Spine divests spine fusion business
Centinel Spine announced that it entered into a definitive agreement to sell its global spine fusion product portfolio to Silony Medical. The companies expect the transaction to close within 45 days. The companies declined to disclose the terms of the divestiture of the portfolio and related assets. West Chester, Pennsylvania–based Centinel Spine says the sale […]
Abbott to acquire insulin management company Bigfoot Biomedical
Abbott (NYSE:ABT) announced today that it entered into a definitive agreement to acquire smart insulin management company Bigfoot Biomedical. The transaction remains subject to customary closing conditions and the companies declined to disclose financial terms. They expect it to close in the third quarter of 2023. Abbott has a longstanding relationship with Bigfoot going back […]
